Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
RVLP RVL Pharmaceuticals
1.200-0.060-4.76%
Close
02/07 16:00 ET
1.2000.0000.00%
Post Mkt Price 02/07 16:00 ET
High
1.260
Open
1.220
Turnover
37.60K
Low
1.200
Pre Close
1.260
Volume
30.74K
Post-Market
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
RVL Pharmaceuticals Files Shelf for Potential Sale of $200 Million Securities, Potential Resale of Shares by 2 Selling Shareholders
04:40 AM EST, 01/30/2023 (MT Newswires) -- RVLP Pharmaceuticals (RVLP) on Friday filed a shelf registration statement for the potential sale of up to $200 million of its securities from time to time,
RVL Pharmaceuticals Files to Sell 39.39M Ordinary Shares for Holders
RVL Pharmaceuticals Files $200M Mixed Securities Shelf
FY2025 EPS Estimates for RVL Pharmaceuticals Plc (NASDAQ:RVLP) Cut by Analyst
RVL Pharmaceuticals plc (NASDAQ:RVLP – Get Rating) – Analysts at Jefferies Financial Group decreased their FY2025 earnings per share (EPS) estimates for shares of RVL Pharmaceuticals in a research
Jefferies Financial Group Comments on RVL Pharmaceuticals Plc's FY2025 Earnings (NASDAQ:RVLP)
RVL Pharmaceuticals plc (NASDAQ:RVLP – Get Rating) – Jefferies Financial Group decreased their FY2025 earnings per share (EPS) estimates for shares of RVL Pharmaceuticals in a research note issued
RVL Pharmaceuticals Stock Soars After Sees Q4 Net Sales of UPNEEQ About $12.1M, up 21% Q/Q
RVL Pharmaceuticals Expects Q4 UPNEEQ Net Product Sales Of ~$12.1M
RVL Pharmaceuticals Expects Q4 UPNEEQ Net Product Sales Of ~$12.1M
RVL Pharmaceuticals Plc's (NASDAQ:RVLP) Profit Outlook
Stocks That Hit 52-Week Lows On Tuesday
 Tuesday's session saw 325 companies set new 52-week lows. 52-Week Low Highlights: Apple (NASDAQ:AAPL) was the biggest company in terms of market cap to set a new 52-week low.InMed Pharmaceuticals
RVL Pharmaceuticals Plc - Ordinary Shares's Return On Capital Employed Overview
RVL Pharmaceuticals plc - Ordinary Shares (NASDAQ:RVLP) brought in sales totaling $10.02 million during Q3 according to data provided by Benzinga Pro. However, earnings decreased 19.33%, resulting in
Company Overview
More
RVL Pharmaceuticals Plc engages in the development and commercialization of products for neurology and women's health. Its products include Upneeq, M-72, Arbaclofen ER, OS870, Divigel, OB Complete, Methylphenidate ER, Venlafaxine ER tablets (VERT), Hydromorphone ER, Sodium Benzoate/Sodium Phenylacetate, Oxybutynin ER, Prescription Prenatal Vitamins, Chlorzoxazone (Lorzone AG), Tramadol ER (ConZip AG), Nitrofurantoin and Osmodex ANDAs. The company was founded in 1986 and is headquartered in Bridgewater, NJ.
CEO： Mr. Brian A. Markison
Market： NASDAQ
Listing Date： 10/18/2018
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet